Dr. Robert William Weisenthal, MD

Dr. Weisenthal practices at CNY Medical and Surgical Eye Care in East Syracuse, New York.

Dr. Weisenthal's NPI, 1508957507, was assigned on September 27, 2006. Dr. Weisenthal graduated from University of Wisconsin School of Medicine and Public Health in 1982. Dr. Weisenthal holds New York license 1740541.

Dr. Weisenthal's primary practice is CNY Medical and Surgical Eye Care, at 5770 Commons Park Dr, East Syracuse, NY 13057 in Onondaga County. The practice phone is (315) 445-1577.

Dr. Weisenthal's primary practice is CNY Medical and Surgical Eye Care in East Syracuse, New York. Dmand AI also links Dr. Weisenthal to 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Weisenthal practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Weisenthal's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Weisenthal is licensed in New York.

CMS data shows 1,286 Medicare services from Dr. Weisenthal across 14 procedure codes in 2024, for 456 Medicare patients. Medicare paid $147,481 for them.

CMS counts 456 Medicare patients who saw Dr. Weisenthal in 2024. The largest group is 75 to 84, with 195 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 5% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Weisenthal's median patient age at 71, with 52% women.

In 2024, Dr. Weisenthal wrote 1,102 Medicare Part D claims for 392 patients. 43% of them were for generic drugs. CMS names the drug for 994 of them, across 16 drugs with 11 or more claims each, at $77,939 in total drug cost. In 2023, CMS named 1,125 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 76 out of 100 for Dr. Weisenthal for performance year 2024, reported as part of a group. Dr. Weisenthal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 314 procedures of cataract surgery by Dr. Weisenthal, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Weisenthal, published from 2020 to 2023. 2021 was the busiest year, with 2. The most frequent topics are Descemet Stripping Endothelial Keratoplasty, Visual Acuity and Descemet Membrane. Dr. Weisenthal has published most often in Cornea. Dr. Weisenthal's most frequent co-authors are Robert Scott Feder, MD, Sadeer B. Hannush, MD and Robert T. Swan, MD.

CMS Open Payments shows 60 general payments to Dr. Weisenthal from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 67% of the total. Alcon Laboratories Inc paid the most, $1,313.

Dr. Weisenthal graduated from University of Wisconsin School of Medicine and Public Health in 1982.